Oorsprong van het eerstegraads netwerk van Martin Savitzky
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Rhone-Poulenc Rorer, Inc.
 Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Rhone-Poulenc Rorer, Inc. discovers, develops and markets human pharmaceuticals. It operates in all major markets of the world. The company is headquartered in Collegeville, PA.
19
| Extinct | Pharmaceuticals: Major | 19 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Martin Savitzky via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| MERCK & CO., INC. | Pharmaceuticals: Major | General Counsel | |
| ABEONA THERAPEUTICS INC. | Pharmaceuticals: Major | President | |
| SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CHEMOCENTRYX, INC. | Pharmaceuticals: Major | Director/Board Member | |
| AEGERION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| IPSEN | Pharmaceuticals: Major | Director/Board Member | |
NormOxys, Inc.
 NormOxys, Inc. Pharmaceuticals: MajorHealth Technology NormOxys, Inc. develops small-molecule therapeutics for the treatment of cancer. Its major product is OXY111A. The company was founded by Conrad J Bletzer, Jr. Claude Nicoalu, Jean-Mearie Lehn, Gay Goodman, Ruth Greferath and Roscoe Brady in 2004 and is headquartered in Brighton, MA. | Pharmaceuticals: Major | Director/Board Member | |
| Stanford University | College/University | Doctorate Degree Masters Business Admin Doctorate Degree | |
| University of Pennsylvania | College/University | Graduate Degree Masters Business Admin Director/Board Member | |
Index Ventures SA
 Index Ventures SA Investment ManagersFinance Index Ventures SA (Index Ventures) is a venture capital firm founded in 1996 by Neil Alexander Rimer, Gluseppe Zocco and Gerald Rimer. The firm is headquartered in Geneva, Switzerland. | Investment Managers | Private Equity Analyst | |
| University of Rhode Island | College/University | Doctorate Degree | |
| HBM HEALTHCARE INVESTMENTS AG | Investment Managers | Corporate Officer/Principal | |
Andera Partners SCA
 Andera Partners SCA Investment ManagersFinance Andera Partners SCA (Andera Partners) is a private equity firm founded in 2001 by Pierre-Michel Passy. The firm is headquartered in Paris, France. | Investment Managers | Corporate Officer/Principal Private Equity Investor | |
| University of Massachusetts | College/University | Doctorate Degree Undergraduate Degree | |
| University of Vermont | College/University | Doctorate Degree | |
Bellus Health (Innodia), Inc.
 Bellus Health (Innodia), Inc. Pharmaceuticals: MajorHealth Technology Bellus Health (Innodia), Inc. manufactures biopharmaceutical products for the treatment and prevention of amyloidosis, metabolic syndrome, and diabetics related diseases. The company was founded in 2002 and is headquartered in Laval, Canada. | Pharmaceuticals: Major | Director/Board Member | |
| WOODBROOK GROUP HOLDINGS INC. | Investment Managers | President | |
HBM Biocapital Ltd.
 HBM Biocapital Ltd. Financial ConglomeratesFinance Part of HBM Partners AG, HBM Biocapital Ltd. is a Caymanian company that provides investment services. The company is based in George Town, Cayman Islands. | Financial Conglomerates | Corporate Officer/Principal | |
| Hoechst Marion Roussel, Inc. | Director/Board Member | ||
OncoEthix SA
 OncoEthix SA Pharmaceuticals: MajorHealth Technology OncoEthix SA operates as a clinical stage biotechnology company which develops cancer drugs. Its products include OTX008, OTX015, and OTX009. The company was founded by Esteban Cvitkovic, Jeanne Kay Noel, Yves Paternot, and Patrice Herait in March 2007 and is headquartered in Luzern, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Bristol-Myers Squibb SARL
 Bristol-Myers Squibb SARL Medical DistributorsDistribution Services Bristol-Myers Squibb SARL engages in the research, development, manufacture, and distribution of pharmaceutical products. Its therapeutic areas include immunoscience, immune-oncology, and cardiology. The company is headquartered in Rueil-Malmaison, France. | Medical Distributors | Corporate Officer/Principal | |
| Sandoz Pharmaceuticals Corp. | Corporate Officer/Principal | ||
LinguaFlex, Inc.
 LinguaFlex, Inc. Medical SpecialtiesHealth Technology LinguaFlex, Inc. develops, manufactures and distributes medical devices for the treatment of sleep apnea. It offers the LinguaFlex Tongue Retractor which is a minimally invasive device designed to be inserted into the tongue by a thin needle. The LinguaFlex Tongue Retractor is designed not to interfere with normal tongue functions such as speech and swallowing and to be removed or replaced in a doctor’s office in a short period of time without the need for anesthesia. The company was founded by Ira Sanders in 2007 and is headquartered in Pittsburgh, PA. | Medical Specialties | Director/Board Member | |
ProFibrix BV
 ProFibrix BV BiotechnologyHealth Technology ProFibrix BV develops and markets products for the hemostasis and regenerative medicine markets. Its product in pipeline, ProFibrix, is a hemostatic agent for mild to moderate surgical bleeding. The firm operates through its offices located in Leiden and Seattle. It is a subsidiary of The Medicines Company. The company was founded in 2004 by Jaap Koopman and is headquartered in Leiden, the Netherlands. | Biotechnology | Director/Board Member | |
| Université Paris Nanterre | College/University | Doctorate Degree | |
Mind-NRG SARL
 Mind-NRG SARL Medical/Nursing ServicesHealth Services Mind-NRG SARL specializes in research and development programs with focus on the treatment psychiatric and neurologic diseases. The company was founded in 2010 and is headquartered in Geneva, Switzerland. | Medical/Nursing Services | Chairman | |
Epsilon-3 Bio Ltd
 Epsilon-3 Bio Ltd Pharmaceuticals: OtherHealth Technology Epsilon-3 Bio Ltd. develops compounds targeting the removal of cellular debris in chronic inflammatory and autoimmune disorders. The company was founded by Martin W. Edwards, Konstantinos Efthymiopoulos, David J. Grainger and Christian De La Tour on June 18, 2010 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Other | Director/Board Member | |
| Max-Planck Institute of Psychiatry | Corporate Officer/Principal | ||
Feldan Bio, Inc.
 Feldan Bio, Inc. Pharmaceuticals: MajorHealth Technology Feldan Bio, Inc. develops, produces and supplies recombinant proteins for therapeutic and research purposes. It specializes in cell culture products, cytokines, enzymes, receptors, clinical grade cytokines, and research proteins. The company was founded by Fran?ois-Thomas Michaud and Francois-Eric Lebeau in 2007 and is headquartered in Quebec, Canada. | Pharmaceuticals: Major | Chairman | |
| MINERVA NEUROSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Stx Pharma Ltd. | Director/Board Member | ||
Medicxi Ventures (Jersey) Ltd.
 Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi Ventures (Jersey) Ltd. (Medicxi) is an independent venture capital firm founded in 2016 by Francesco de Rubertis, Michèle Ollier, and Kevin S. Johnson. The firm is headquartered in London. | Investment Managers | Founder | |
Gadeta BV
 Gadeta BV Medical SpecialtiesHealth Technology Gadeta BV discovers and develops novel cancer immunotherapies. It provides groundbreaking discoveries regarding the role of cell receptors in the broad of heamatological and solid tumor cells. The firm develops t-cells engineered to express a defined gamma delta, an anti- cancer product that eradicates tumors. The company was founded by Jurgen Kuball in 2015 and is headquartered in Utrecht, Netherlands. | Medical Specialties | Director/Board Member | |
Salarius Pharmaceuticals LLC
 Salarius Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Salarius Pharmaceuticals LLC manufactures drugs for cancer. It specializes in epigenetics, pipeline and LSD1 research, and development services. The company was founded by Jonathan P. Northrup and Sharma Sunil in 2014 and is headquartered in Houston, TX. | Pharmaceuticals: Major | Director/Board Member | |
Palladio Biosciences, Inc.
 Palladio Biosciences, Inc. BiotechnologyHealth Technology Palladio Biosciences, Inc. develops transformative medicines for orphan diseases. Its pipeline includes Lixivaptan, a selective vasopressin V2 receptor antagonist for the treatment of polycystic kidney disease, a life-threatening genetic disease. The company was founded by Lorenzo Pellegrini in 2015 and is headquartered in Newtown, PA. | Biotechnology | Director/Board Member | |
| SATELLOS BIOSCIENCE INC. | Pharmaceuticals: Major | Director/Board Member | |
| LISATA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| Essex Chimie AG | Chief Executive Officer |
Statistieken
Internationaal
| Verenigde Staten | 27 |
| Zwitserland | 7 |
| Frankrijk | 6 |
| Canada | 5 |
| Verenigd Koninkrijk | 5 |
Sectoraal
| Health Technology | 27 |
| Finance | 8 |
| Consumer Services | 7 |
| Health Services | 4 |
| Commercial Services | 2 |
Operationeel
| Director/Board Member | 103 |
| Corporate Officer/Principal | 62 |
| Chairman | 29 |
| President | 21 |
| Chief Executive Officer | 19 |
Sterkste connecties
| Insiders | |
|---|---|
| Michèle Ollier | 33 |
| Michel de Rosen | 28 |
| David Mazzo | 23 |
| Gilles Nobécourt | 19 |
| Robert Cawthorn | 17 |
| Patrick Lee | 15 |
| Gary T. Shearman | 13 |
| Fred Banti | 11 |
| Brian Schwab | 11 |
| William McVicar | 11 |
| Thomas B. Okarma | 10 |
| Martin P. Galvan | 9 |
| Christophe M. Bianchi | 9 |
| Jeffrey M. Dener | 8 |
| Richard Collier | 8 |
- Beurs
- Insiders
- Martin Savitzky
- Bedrijfsconnecties
